| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Simvastatin | FAERS: 5 | US FAERS | |
| 2 | Zoledronic Acid | FAERS: 4 | US FAERS | |
| 3 | Hydrochlorothiazide | FAERS: 2 | US FAERS | |
| 4 | Methotrexate | FAERS: 2 | US FAERS | |
| 5 | ledipasvir, sofosbuvir drug combination | FAERS: 2 | US FAERS | |
| 6 | Bortezomib | FAERS: 1 | US FAERS | |
| 7 | Carboplatin | FAERS: 1 | US FAERS | |
| 8 | Exenatide | FAERS: 1 | US FAERS | |
| 9 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 10 | Lenalidomide | FAERS: 1 | US FAERS | |
| 11 | Thrombin | FAERS: 1 | US FAERS | |
| 12 | bicalutamide | FAERS: 1 | US FAERS | |
| 13 | hydrochlorothiazide-triamterene | FAERS: 1 | US FAERS | |
| 14 | Modafinil | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | carbidopa, levodopa drug combination | Canada Vigilance: 3 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.